David Einhorn - DME Capital Management
Holding/activity history for Neubase Therapeutics Inc (OHRPGBP)
← All OHRPGBP superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q2 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2023 Q1 | 2,727,027 | 0.03 | $0.19 | $504,500 | SEC | ||
| 2022 Q4 | 2,727,027 | 0.04 | $0.19 | $518,681 | SEC | ||
| 2022 Q3 | 2,727,027 | 0.08 | $0.39 | $1,077,000 | SEC | ||
| 2022 Q2 | 2,727,027 | 0.22 | $1.05 | $2,863,000 | SEC | ||
| 2022 Q1 | 2,727,027 | 0.33 | $1.88 | $5,127,000 | SEC | ||
| 2021 Q4 | 2,727,027 | 0.44 | $2.81 | $7,663,000 | SEC | ||
| 2021 Q3 | 2,727,027 | 0.66 | $3.61 | $9,844,000 | SEC | ||
| 2021 Q2 | 2,727,027 | 0.83 | Add 34.53% | 0.21 | $4.79 | $13,062,000 | SEC |
| 2021 Q1 | 2,027,027 | 1.07 | $7.39 | $14,980,000 | SEC | ||
| 2020 Q4 | 2,027,027 | 0.87 | $6.99 | $14,169,000 | SEC | ||
| 2020 Q3 | 2,027,027 | 1.27 | Add 6.50% | 0.08 | $7.59 | $15,386,000 | SEC |
| 2020 Q2 | 1,903,227 | 1.83 | Add 23.71% | 0.35 | $8.78 | $16,711,000 | SEC |
| 2020 Q1 | 1,538,462 | 1.57 | $7.12 | $10,954,000 | SEC | ||
| 2019 Q4 | 1,538,462 | 0.82 | $7.20 | $11,077,000 | SEC | ||
| 2019 Q3 | 1,538,462 | 0.55 | Buy | 0.55 | $4.99 | $7,677,000 | SEC |